Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2013; 19(33): 5542-5550
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5542
Table 1 Case characteristics n (%)
CharacteristicsIBL (mL)
χ2P value
< 200200-400> 400
IBL (mean ± SD)99.3 ± 25.0223.2 ± 41.6484.4 ± 179.9
Gender4.3070.116
Male269 (70.2)285 (71.6)53 (71.8)
Female114 (29.8)113 (28.4)11 (28.2)
Age (yr)2.4880.288
≤ 65230 (60.1)227 (57.0)32 (50.0)
> 65153 (39.9)171 (43.0)32 (50.0)
Tumor location40.555< 0.001
Lower 1/3205 (53.5)148 (37.2)14 (21.9)
Middle 1/336 (9.4)41 (10.3)6 (9.4)
Upper 1/398 (25.6)164 (41.2)34 (53.1)
2/3 or more44 (11.5)45 (11.3)10 (15.6)
Tumor size17.677< 0.001
< 5 cm180 (47.0)155 (38.9)13 (20.3)
≥ 5 cm203 (53.0)243 (61.1)51 (79.7)
Borrmann type5.1800.075
I/II169 (44.1)153 (38.4)33 (51.6)
III/IV214 (55.9)245 (61.6)31 (48.4)
Histology0.9820.612
Differentiated121 (31.6)139 (34.9)21 (32.8)
Undifferentiated262 (68.4)259 (65.1)43 (67.2)
Extranodal metastasis1.9630.375
Positive59 (15.4)71 (17.8)14 (21.9)
Negative324 (84.6)327 (82.2)50 (78.1)
Depth of invasion14.7190.023
pT114 (3.7)11 (2.8)0 (0.0)
pT253 (13.8)44 (11.1)0 (0.0)
pT321 (5.5)28 (7.0)6 (9.4)
pT4295 (77.0)315 (79.1)58 (90.6)
Lymph node metastasis15.7930.015
pN0173 (45.2)146 (36.7)19 (29.7)
pN156 (14.6)82 (20.6)9 (14.1)
pN285 (22.2)87 (21.9)15 (23.4)
pN369 (18.0)83 (20.9)21 (32.8)
TNM stage15.3130.004
I53 (13.8)43 (10.8)0 (0.0)
II132 (34.5)118 (29.6)19 (29.7)
III198 (51.7)237 (59.5)45 (70.3)
Chemotherapy2.0360.361
Yes104 (27.2)119 (29.9)14 (21.9)
No279 (72.8)279 (70.1)50 (78.1)
Type of gastrectomy37.357< 0.001
Total51 (13.3)117 (29.4)24 (37.5)
Subtotal332 (86.7)281 (70.6)40 (62.5)
Combined organ resection22.256< 0.001
Yes16 (4.2)38 (9.5)13 (20.3)
No367 (95.8)360 (90.5)51 (79.7)
Extent of lymphadenectomy7.2300.027
D2 and D2+189 (49.3)188 (47.2)20 (31.3)
D1194 (50.7)210 (52.8)44 (68.8)
Postoperative complications7.5000.024
Present20 (5.2)34 (8.5)9 (14.1)
Absent363 (94.8)364 (91.5)55 (85.9)